Teladoc Health, Inc. (TDOC)
USD 9.46
(-6.06%)
USD 9.46
(-6.06%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -248.55 Million USD | -101.88% |
| 2022 | 13.19 Billion USD | 5622.65% |
| 2021 | -238.98 Million USD | 42.85% |
| 2020 | -418.18 Million USD | -466.48% |
| 2019 | -73.82 Million USD | -4.19% |
| 2018 | -70.85 Million USD | 6.02% |
| 2017 | -75.39 Million USD | -20.31% |
| 2016 | -62.66 Million USD | -12.33% |
| 2015 | -55.78 Million USD | -268.22% |
| 2014 | -15.15 Million USD | -158.14% |
| 2013 | -5.86 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -49.19 Million USD | 36.18% |
| 2024 Q1 | -77.07 Million USD | 11.54% |
| 2024 Q3 | -44.4 Million USD | 9.74% |
| 2023 Q1 | -49.01 Million USD | -101.31% |
| 2023 Q3 | -64.72 Million USD | -35.74% |
| 2023 Q4 | -87.13 Million USD | -34.62% |
| 2023 FY | -248.55 Million USD | -101.88% |
| 2023 Q2 | -47.68 Million USD | 2.71% |
| 2022 FY | 13.19 Billion USD | 5622.65% |
| 2022 Q4 | 3.75 Billion USD | 5447.9% |
| 2022 Q1 | -64.87 Million USD | -74.04% |
| 2022 Q2 | -63.66 Million USD | 1.87% |
| 2022 Q3 | -70.13 Million USD | -10.17% |
| 2021 FY | -238.98 Million USD | 42.85% |
| 2021 Q4 | -37.27 Million USD | 38.47% |
| 2021 Q3 | -60.57 Million USD | 23.27% |
| 2021 Q1 | -84.67 Million USD | 81.53% |
| 2021 Q2 | -78.94 Million USD | 6.77% |
| 2020 Q4 | -458.5 Million USD | -2224.49% |
| 2020 Q3 | -19.72 Million USD | -174.76% |
| 2020 FY | -418.18 Million USD | -466.48% |
| 2020 Q1 | -21.01 Million USD | -34.79% |
| 2020 Q2 | -7.17 Million USD | 65.83% |
| 2019 Q1 | -22.88 Million USD | -28.31% |
| 2019 Q3 | -19.94 Million USD | 9.44% |
| 2019 Q2 | -22.02 Million USD | 3.78% |
| 2019 Q4 | -15.58 Million USD | 21.84% |
| 2019 FY | -73.82 Million USD | -4.19% |
| 2018 Q3 | -15.77 Million USD | 13.05% |
| 2018 Q1 | -19.09 Million USD | 22.26% |
| 2018 FY | -70.85 Million USD | 6.02% |
| 2018 Q4 | -17.83 Million USD | -13.05% |
| 2018 Q2 | -18.14 Million USD | 4.95% |
| 2017 Q4 | -24.55 Million USD | -14.01% |
| 2017 FY | -75.39 Million USD | -20.31% |
| 2017 Q3 | -21.54 Million USD | -48.64% |
| 2017 Q2 | -14.49 Million USD | 2.09% |
| 2017 Q1 | -14.8 Million USD | -11.88% |
| 2016 Q2 | -14.46 Million USD | 1.72% |
| 2016 Q1 | -14.71 Million USD | -2.57% |
| 2016 Q4 | -13.23 Million USD | 34.69% |
| 2016 FY | -62.66 Million USD | -12.33% |
| 2016 Q3 | -20.25 Million USD | -40.07% |
| 2015 Q1 | -12.59 Million USD | -101.58% |
| 2015 FY | -55.78 Million USD | -268.22% |
| 2015 Q4 | -14.34 Million USD | -13.9% |
| 2015 Q3 | -12.59 Million USD | 22.5% |
| 2015 Q2 | -16.25 Million USD | -29.05% |
| 2014 Q1 | -2.18 Million USD | 0.0% |
| 2014 Q3 | -3.85 Million USD | -34.95% |
| 2014 Q4 | -6.24 Million USD | -61.97% |
| 2014 Q2 | -2.85 Million USD | -30.62% |
| 2014 FY | -15.15 Million USD | -158.14% |
| 2013 FY | -5.86 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| American Well Corporation | -692.14 Million USD | 64.089% |
| Doximity, Inc. | 163.87 Million USD | 251.67% |
| Evolent Health, Inc. | -71.21 Million USD | -249.037% |
| MultiPlan Corporation | 173.4 Million USD | 243.338% |
| Phreesia, Inc. | -131.77 Million USD | -88.622% |
| Veeva Systems Inc. | 429.33 Million USD | 157.893% |